Joint modelling of time-to-clinical malaria and parasite count in a cohort in an endemic area.
Cox proportional hazards model
Prospective studies
clinical malaria
joint modelling
longitudinal data
malaria parasite
time-to-event
Journal
Journal of medical statistics and informatics
ISSN: 2053-7662
Titre abrégé: J Med Stat Inform
Pays: England
ID NLM: 101632234
Informations de publication
Date de publication:
2019
2019
Historique:
entrez:
28
6
2019
pubmed:
28
6
2019
medline:
28
6
2019
Statut:
ppublish
Résumé
In malaria endemic areas such as sub-Saharan Africa, repeated exposure to malaria results in acquired immunity to clinical disease but not infection. In prospective studies, time-to-clinical malaria and longitudinal parasite count trajectory are often analysed separately which may result in inefficient estimates since these two processes can be associated. Including parasite count as a time-dependent covariate in a model of time-to-clinical malaria episode may also be inaccurate because while clinical malaria disease frequently leads to treatment which may instantly affect the level of parasite count, standard time-to-event models require that time-dependent covariates be external to the event process. We investigated whether jointly modelling time-to-clinical malaria disease and longitudinal parasite count improves precision in risk factor estimates and assessed the strength of association between the hazard of clinical malaria and parasite count. Using a cohort data of participants enrolled with uncomplicated malaria in Malawi, a conventional Cox Proportional Hazards (PH) model of time-to-first clinical malaria episode with time-dependent parasite count was compared with three competing joint models. The joint models had different association structures linking a quasi-Poisson mixed-effects of parasite count and event-time Cox PH sub-models. There were 120 participants of whom 115 (95.8%) had >1 follow-up visit and 100 (87.5%) experienced the episode. Adults >15 years being reference, log hazard ratio for children <5 years was 0.74 (95% CI: 0.17, 1.26) in the joint model with best fit vs. 0.62 (95% CI: 0.04, 1.18) from the conventional Cox PH model. The log hazard ratio for the 5-15 years was 0.72 (95% CI: 0.22, 1.22) in the joint model vs.0.63 (95% CI: 0.11, 1.17) in the Cox PH model. The area under parasite count trajectory was strongly associated with the risk of clinical malaria, with a unit increase corresponding to-0.0012 (95% CI: -0.0021, -0.0004) decrease in log hazard ratio. Jointly modelling longitudinal parasite count and time-to-clinical malaria disease improves precision in log hazard ratio estimates compared to conventional time-dependent Cox PH model. The improved precision of joint modelling may improve study efficiency and allow for design of clinical trials with relatively lower sample sizes with increased power.
Sections du résumé
BACKGROUND
BACKGROUND
In malaria endemic areas such as sub-Saharan Africa, repeated exposure to malaria results in acquired immunity to clinical disease but not infection. In prospective studies, time-to-clinical malaria and longitudinal parasite count trajectory are often analysed separately which may result in inefficient estimates since these two processes can be associated. Including parasite count as a time-dependent covariate in a model of time-to-clinical malaria episode may also be inaccurate because while clinical malaria disease frequently leads to treatment which may instantly affect the level of parasite count, standard time-to-event models require that time-dependent covariates be external to the event process. We investigated whether jointly modelling time-to-clinical malaria disease and longitudinal parasite count improves precision in risk factor estimates and assessed the strength of association between the hazard of clinical malaria and parasite count.
METHODS
METHODS
Using a cohort data of participants enrolled with uncomplicated malaria in Malawi, a conventional Cox Proportional Hazards (PH) model of time-to-first clinical malaria episode with time-dependent parasite count was compared with three competing joint models. The joint models had different association structures linking a quasi-Poisson mixed-effects of parasite count and event-time Cox PH sub-models.
RESULTS
RESULTS
There were 120 participants of whom 115 (95.8%) had >1 follow-up visit and 100 (87.5%) experienced the episode. Adults >15 years being reference, log hazard ratio for children <5 years was 0.74 (95% CI: 0.17, 1.26) in the joint model with best fit vs. 0.62 (95% CI: 0.04, 1.18) from the conventional Cox PH model. The log hazard ratio for the 5-15 years was 0.72 (95% CI: 0.22, 1.22) in the joint model vs.0.63 (95% CI: 0.11, 1.17) in the Cox PH model. The area under parasite count trajectory was strongly associated with the risk of clinical malaria, with a unit increase corresponding to-0.0012 (95% CI: -0.0021, -0.0004) decrease in log hazard ratio.
CONCLUSION
CONCLUSIONS
Jointly modelling longitudinal parasite count and time-to-clinical malaria disease improves precision in log hazard ratio estimates compared to conventional time-dependent Cox PH model. The improved precision of joint modelling may improve study efficiency and allow for design of clinical trials with relatively lower sample sizes with increased power.
Identifiants
pubmed: 31245015
doi: 10.7243/2053-7662-7-1
pmc: PMC6594707
mid: NIHMS1036455
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : FIC NIH HHS
ID : D43 TW010075
Pays : United States
Organisme : NIAID NIH HHS
ID : K24 AI114996
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI089683
Pays : United States
Déclaration de conflit d'intérêts
Competing interests The authors declare that they have no competing interests.
Références
Biometrics. 2002 Dec;58(4):742-53
pubmed: 12495128
Control Clin Trials. 2002 Dec;23(6):626-34
pubmed: 12505241
Biometrics. 2003 Jun;59(2):221-8
pubmed: 12926706
J Biopharm Stat. 2004 Nov;14(4):1005-19
pubmed: 15587977
Biometrics. 2006 Jun;62(2):432-45
pubmed: 16918907
Scand J Immunol. 2008 Feb;67(2):177-84
pubmed: 18086262
J Clin Oncol. 2010 Jun 1;28(16):2796-801
pubmed: 20439643
Malar J. 2011 Jun 24;10:173
pubmed: 21699741
Clin Infect Dis. 2013 Feb;56(3):383-97
pubmed: 23087389
PLoS One. 2013;8(2):e55666
pubmed: 23405191
Am J Trop Med Hyg. 2013 Apr;88(4):727-732
pubmed: 23419363
Am J Trop Med Hyg. 2013 Nov;89(5):840-849
pubmed: 24062477
Stat Med. 2015 Jun 30;34(14):2181-95
pubmed: 24634327
Stat Med. 2014 Nov 20;33(26):4560-76
pubmed: 24947785
PLoS One. 2015 Jul 24;10(7):e0134061
pubmed: 26207758
Malar J. 2016 Jul 15;15:361
pubmed: 27417903
Malar J. 2016 Dec 8;15(1):590
pubmed: 27931234
Malar J. 2017 Feb 23;16(1):88
pubmed: 28231817
Clin Infect Dis. 2019 Jan 1;68(1):106-112
pubmed: 29788054